Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Better Vaccine Stock: Ocugen vs. Inovio Pharmaceuticals

TheMotleyFool

0 0

Better Vaccine Stock: Ocugen vs. Inovio Pharmaceuticals

The pandemic is dragging on. With the newer and more contagious omicron variant of the virus that causes COVID-19 now spreading quickly, we aren't out of the woods just yet. These latest developments again highlight the importance of potent vaccines as a tool to fight the outbreak.

And while there are plenty of companies already offering vaccines, two biotechs that still plan to make some noise in this market are Ocugen (NASDAQ: OCGN) and Inovio Pharmaceuticals (NASDAQ: INO). These vaccine makers are underdogs, but which one is more likely to perform well in 2022 and beyond? Let's look closer into both companies' businesses and pick a likely winner.

Data by YCharts.